Immunotech Biopharm Ltd

06978

Company Profile

  • Business description

    Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

  • Contact

    No.1 Kangding Street
    8th Floor, Block 1, Guosheng Technology Park
    Beijing Economic-technological Development Area
    Beijing100176
    CHN

    T: +86 8610884002

    https://www.eaal.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    173

Stocks News & Analysis

stocks

Procter & Gamble earnings: Frigid sales and margins don’t suggest cracks in its standing

North America was a notable blemish, down 2% on an organic basis.
stocks

Our view on Santos after production is ramped up

Barossa at 75% capacity and Pikka undergoing commissioning.
stocks

GE Aerospace earnings: No good deed goes unpunished

We’ve raised our fair value estimate of GE Aerospace stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,210.7036.500.40%
CAC 408,148.8979.720.99%
DAX 4024,856.47295.491.20%
Dow JONES (US)49,384.01306.780.63%
FTSE 10010,150.0511.960.12%
HKSE26,797.07167.110.63%
NASDAQ23,436.02211.200.91%
Nikkei 22553,851.87162.980.30%
NZX 50 Index13,498.5758.30-0.43%
S&P 5006,913.3537.730.55%
S&P/ASX 2008,880.3035.200.40%
SSE Composite Index4,136.4613.880.34%

Market Movers